BIMEKIZUMAB-BKZX for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 3,059 adverse event reports in the FDA FAERS database where BIMEKIZUMAB-BKZX was used for Psoriasis.
Most Reported Side Effects for BIMEKIZUMAB-BKZX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product dose omission issue | 694 | 13.0% | 0 | 24 |
| Psoriasis | 621 | 11.6% | 0 | 9 |
| Drug ineffective | 402 | 7.5% | 0 | 11 |
| Product availability issue | 364 | 6.8% | 0 | 17 |
| Off label use | 335 | 6.3% | 3 | 39 |
| Psoriatic arthropathy | 301 | 5.6% | 0 | 15 |
| Injection site pain | 263 | 4.9% | 0 | 8 |
| Therapy interrupted | 252 | 4.7% | 0 | 15 |
| Hidradenitis | 233 | 4.4% | 0 | 14 |
| Inappropriate schedule of product administration | 214 | 4.0% | 0 | 11 |
| Incorrect dose administered | 209 | 3.9% | 0 | 5 |
| Oral candidiasis | 178 | 3.3% | 0 | 9 |
| Pain | 159 | 3.0% | 1 | 5 |
| Fatigue | 148 | 2.8% | 0 | 6 |
| Headache | 146 | 2.7% | 0 | 7 |
Other Indications for BIMEKIZUMAB-BKZX
Psoriatic arthropathy (1,033)
Product used for unknown indication (716)
Hidradenitis (598)
Ankylosing spondylitis (199)
Off label use (199)
Axial spondyloarthritis (55)
Rheumatoid arthritis (39)
Dermatitis atopic (31)
Illness (21)
Pustular psoriasis (20)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)